Inotiv (STU:BS50) Receivables Turnover : 1.79 (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Inotiv Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Inotiv's Revenue for the three months ended in Mar. 2024 was €109.5 Mil. Inotiv's average Accounts Receivable for the three months ended in Mar. 2024 was €61.3 Mil. Hence, Inotiv's Receivables Turnover for the three months ended in Mar. 2024 was 1.79.

Inotiv Receivables Turnover Historical Data

The historical data trend for Inotiv's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inotiv Receivables Turnover Chart

Inotiv Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Receivables Turnover

Get a 7-Day Free Trial

7.88

7.39

5.69

10.13

6.60

Inotiv Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Receivables Turnover	Get a 7-Day Free Trial															2.31	2.24	1.86	1.72	1.79

Competitive Comparison of Inotiv's Receivables Turnover

For the Diagnostics & Research subindustry, Inotiv's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Inotiv's Receivables Turnover Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Inotiv's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Inotiv's Receivables Turnover falls into.

Inotiv Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Inotiv's Receivables Turnover for the fiscal year that ended in Sep. 2023 is calculated as

	Receivables Turnover (A: Sep. 2023 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Sep. 2023 )	/ (	(Accounts Receivable (A: Sep. 2022 )	+	Accounts Receivable (A: Sep. 2023 ))	/	count )
=	536.362	/ (	(89.756	+	72.728)	/	2 )
=	536.362	/	81.242
=	6.60

Inotiv's Receivables Turnover for the quarter that ended in Mar. 2024 is calculated as

	Receivables Turnover (Q: Mar. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Mar. 2024 )	/ (	(Accounts Receivable (Q: Dec. 2023 )	+	Accounts Receivable (Q: Mar. 2024 ))	/	count )
=	109.512	/ (	(71.959	+	50.619)	/	2 )
=	109.512	/	61.289
=	1.79

Inotiv (STU:BS50) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Inotiv Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Inotiv's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Inotiv (STU:BS50) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Inotiv Inc (STU:BS50) » Definitions » Receivables Turnover

Comparable Companies

STIM FONR BNR ACRS PRPH VNRX MDXH BDSX BIOQ PSNL TMO DHR IQV XSWX:LONN IDXX A MTD ICLR ILMN WAT

Traded in Other Exchanges

NOTV:USA

Address

2701 Kent Avenue, West Lafayette, IN, USA, 47906

Website

https://www.inotivco.com

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, it supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through the RMS segment, it offers access to a wide range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas. It earns maximum revenue from RMS Segment.

Inotiv (STU:BS50) Headlines

No Headlines